Practical Strategies for Implementing an Effective Neurodegenerative Biomarker Program into Your Clinical Trial & Diagnostic Transition

Hear Kathy Landshulz, Therapeutic Area Lead, Biomarker Solution Center, Labcorp Oncology, keynote presentation from the World CDx US 2022 conference, "Practical Strategies for Implementing an Effective Neurodegenerative Biomarker Program into Your Clinical Trial and Diagnostic Transition." The presentation covers deploying the right biomarkers, platforms, technology and reagents to drive context-of-use appropriate data delivery, leveraging new biomarkers, platforms, strategies in Alzheimer's Disease clinical trial design and how effective biomarker strategies utilized during drug development can inform future clinical care.